Platelets Activation in Brain Neoplasms

Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Sep 10, 2021

Keywords

ClinConnect Summary

This clinical trial is exploring the role of platelets—small cells in our blood that help with clotting—in brain tumors, specifically gliomas. Researchers believe that platelets do more than just help with bleeding; they might also influence how tumors grow and spread. This study aims to find out if platelets are part of the environment around brain tumors and how their presence might affect patient outcomes. By understanding this, the researchers hope to improve treatments for brain tumors.

To participate in this study, you need to be at least 18 years old and scheduled for surgery or a biopsy of a brain tumor. You'll also need to give your consent to join the trial and be a member of the Social Security system. If you join, you might undergo additional tests on your tumor sample to help researchers learn more about the connection between platelets and brain tumors. This research could lead to new ways to enhance cancer treatments in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient to undergo excision or biopsy of a brain or medullary tumor
• • Patient over 18 years old
• • Express consent to participate in the study
• • Affiliate member of the Social Security system
• Exclusion Criteria:
• • Tumor sample volume not allowing the performance of additional analyzes
• • Patient benefiting from a legal protection measure
• • Pregnant or breastfeeding woman